July 27, 2012 — Siemens Healthcare (booth 707) will be at the 2012 Annual Meeting of the American Association of ...
PET Imaging
Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enables visualization of metabolic processes in the body. The basics of PET imaging is that the technique detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (also called radiopharmaceuticals, radionuclides or radiotracer). The tracer is injected into a vein on a biologically active molecule, usually a sugar that is used for cellular energy. PET systems have sensitive detector panels to capture gamma ray emissions from inside the body and use software to plot to triangulate the source of the emissions, creating 3-D computed tomography images of the tracer concentrations within the body.
July 25, 2012 — Positron Corp. announced approval of a pledge for $15 million in tax increment financing (TIF) bonds ...
The last 20 years have brought about great advances in breast cancer detection and treatment. Among them has been the ...
Digital technology is opening remarkable opportunities for clinical positron emission tomography (PET) about which ...
July 24, 2012 — Navidea Biopharmaceuticals Inc., a specialty pharmaceutical company focused on precision diagnostic ...
July 23, 2012 — GE Healthcare announced the final results from a Phase III study of the investigational PET (positron ...
July 13, 2012 — Royal Philips Electronics announced that it has embarked on a five-year joint research and development ...
Precision can have an enormous impact on patients. From diagnosis to patient monitoring (see “How Digital PET/CT Can ...
June 20, 2012 — The Society of Nuclear Medicine’s (SNM) 2012 Image of the Year illustrates the effectiveness of Bi-213 ...
June 15, 2012 — Data presented at the Society for Nuclear Medicine (SNM) Annual Meeting shows that uptake of the ...
June 15, 2012 — Several groundbreaking studies on the Naviscan PET scanner, the breast application for which is positron ...
PET is getting ready to venture outside oncology, cardiology and mainstream neurology. High on the list of new clinical ...
June 15, 2012 — At the Society of Nuclear Medicine (SNM) 2012, GE Healthcare showcased Q.Suite on both the new Discovery ...
June 14, 2012 — Addicts unable to kick a cocaine habit could one day be vaccinated against cocaine and see proof with a ...
June 8, 2012 — At this year’s SNM Annual Meeting, June 9-13, Philips Healthcare is highlighting its portfolio of nuclear ...
Analog is approximate. Digital is specific. Therein lies the fundamental difference between digital PET and its analog ...
June 7, 2012 – For those with esophageal cancer, initial staging of the disease is of particular importance as it ...
June 4, 2012 — GE Healthcare signed an agreement with Affibody AB (“Affibody”) to collaborate on the development of a ...
June 4, 2012 — Eli Lilly and Co. and Avid Radiopharmaceuticals Inc. announced Amyvid is available to imaging centers in ...
Magnetic resonance/positron emission tomography (MR/PET) is the newest imaging modality falling within the category of ...
May 21, 2012 — The Kimmel Cancer Center and the Department of Radiology at Thomas Jefferson University in Pennsylvania ...
May 18, 2012 — Alzheimer’s disease (AD) is a neurodegenerative disease of the brain characterized by beta-amyloid ...
May 18, 2012 - New research from the University at Buffalo suggests that cardiologists may have a new way to identify ...
Since it was named “Invention of the Year” by TIME magazine in 2000, positron emission tomography/computed tomography ...